Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Smaller portions feel satisfying
Product Specifications The Body Pharm Retatrutide 64mg pen is a multi-dose subcutaneous injection device containing 64mg of lyophilised-then-solubilised retatrutide (LY3437943), a synthetic GIP/GLP-1/glucagon triple receptor agonist developed by Eli Lilly and currently in Phase 3 obesity trials [7][6]
Energy Boosting Patients with chronic illnesses experience less fatigue and higher energy with IV supplementation
[16] [17] Many patients with type 2 diabetes or obesity also have cardiovascular comorbidities requiring anticoagulation therapy
Practical self-management strategies include: Adequate hydration : Maintain good fluid intake throughout the day, particularly if experiencing gastrointestinal side effects
US$ 29.15
US$ 29.68
US$ 29.63
US$ 26.07
US$ 20.92
US$ 20.33
US$ 24.51
